On June 12, 2026, SpaceX priced its initial public offering at $135 a share, valuing the company at $1.77 trillion and making it, by a wide margin, the largest listing in the history of capital markets. The stock popped 19% on debut, briefly pushing the company’s market value past $2 trillion and into the ranks of America’s six largest listed corporations. Financial television treated it as a coronation: the ultimate proof that even the most secretive, founder-controlled companies eventually open themselves to the public.
They left out the second half of the story. By late July, six weeks after the opening bell, SpaceX shares had fallen roughly 50% from their peak. The float that reached ordinary investors was a sliver of the company, cleared only after regulators granted a waiver from normal listing minimums. Institutions took 70% of the offering; retail got 30%, and Chinese and Hong Kong investors were barred outright on export-control grounds. Analysts who studied the mechanics of the deal described “manufactured scarcity” engineered, in part, through index-inclusion rules that all but guaranteed a first-day scramble for shares among funds tracking the benchmarks SpaceX would soon join.

None of that is a scandal. It is simply what a public offering looks like when a company waits twenty-four years to hold one. And it is the clearest illustration yet of a structural shift that most executives have registered as a financing curiosity rather than what it actually is: a quiet redistribution of who gets to own the compounding.
The vanishing public company
The raw numbers are not new, but they have compounded quietly for three decades. The number of publicly listed companies in the United States fell from roughly 8,000 in 1996 to about 4,600 by 2022, even as the American economy nearly doubled in real terms. The median age of a company at IPO has climbed alongside it, from around eight or nine years through most of the 1980s and 1990s to twelve years or more across the past two IPO cycles. Stripe, founded in 2010, is still private sixteen years later, valued near $159 billion after a February 2026 tender offer gave employees and early shareholders a way to cash out without a listing. Anthropic, founded in 2021, has already raised more than $130 billion in cumulative funding and was nearing a $1 trillion valuation by mid-2026, still with no listing date. OpenAI closed a $6.6 billion employee share sale at a $500 billion valuation in October 2025, then wrapped a further $7 billion sale at $852 billion less than a year later — a company effectively re-pricing itself every few months in transactions retail investors cannot participate in, long before any prospectus exists.
The standard explanation is capital abundance: sovereign wealth funds, private equity megafunds and continuation vehicles have made so much growth capital available privately that going public is now optional rather than necessary. That explanation is true but incomplete, and the incompleteness matters. Cheap private capital doesn’t just make an IPO unnecessary; it makes waiting profitable in a specific, asymmetric way. Every additional year a company stays private is a year in which its most dramatic value creation — the stretch where a $500 billion valuation becomes $850 billion, or where SpaceX’s own private markups compounded toward $1.5 trillion before a share ever traded publicly — accrues entirely to insiders: founders, employees with vested equity, venture funds, and the sovereign and institutional capital that can write nine-figure checks into a funding round. The public market, when it finally arrives, is not being offered a stake in the growth story. It is being offered the right to buy in at the top of one, priced by people who have every incentive to sell into maximum enthusiasm.
SpaceX’s post-IPO trajectory is the tell. A company doesn’t fall 50% in six weeks because the business deteriorated. It falls because there was no genuine price discovery left to do — the multiple had already been set, and reset, and set again, in a sequence of private markups that public shareholders had no part in and no visibility into until the very end.
The proxy market retail built for itself
Locked out of direct access, retail capital did what it always does: it found a workaround, and paid handsomely for the privilege. Closed-end vehicles like Destiny Tech100 (DXYZ), which holds stakes in SpaceX, OpenAI and Anthropic, began trading at what analysts flatly called “a massive premium” to the net asset value of the private holdings underneath them — investors bidding up a wrapper because the thing inside it was otherwise unreachable. It is a strange inversion of what liquidity is supposed to do: rather than making an asset cheaper to trade, illiquidity at the source made a liquid proxy for it more expensive than the asset itself.
This has a quiet but serious second-order consequence for anyone managing a pension fund, an index-tracking retirement account, or a corporate treasury with exposure to broad equity benchmarks. When index providers bend inclusion rules to accommodate a newly listed giant with a wafer-thin float, they are importing volatility that behaves nothing like the volatility of a normally distributed, widely held stock — and they are doing it inside vehicles that tens of millions of retirement savers assume are diversified and boring. The risk that used to sit with venture investors, who are paid for illiquidity and understand it, is being transferred by degrees into instruments that were never designed to hold it.

What this means at the boardroom level
For a CEO or CFO, the practical questions are less about SpaceX specifically and more about what the choice to stay private actually optimizes for. Extended private tenure buys freedom from quarterly scrutiny and activist pressure, but it also removes an external discipline that founders often underestimate the value of — the market’s willingness to say no. Companies substituting periodic tender offers for public listings, as Stripe and OpenAI now do routinely, are effectively manufacturing their own liquidity events on their own terms and timetable. That is a legitimate strategy for retention, but it concentrates enormous discretionary power over who gets paid, when, and at what valuation, entirely inside management’s hands. Boards overseeing companies on this path should be asking, explicitly, who benefits most from staying private one more year, and whether that answer would survive being said out loud to the employees and investors excluded from the next tender round.
There is also a competitive-allocation effect that gets little attention: as trillions of dollars in private capital chase a small number of AI-adjacent mega-companies, capital that would once have funded a broader pipeline of mid-sized IPOs is being concentrated at the very top of the market. That starves the next tier of ambitious companies of both money and public-market attention precisely when they need it.
India offers a genuine, and instructive, counter-model. Indian IPO markets had a record 2025, with 103 mainboard listings raising roughly ₹1.76 trillion, and Sebi’s pipeline for 2026 includes more than 190 companies awaiting approval, among them Reliance Jio, Flipkart and PhonePe. Listing remains India’s default mechanism for scaling and for liquidity, not a last resort after private markets are exhausted. That earlier public exposure carries real execution risk for investors, since companies list before reaching the scale and moat that today’s American mega-privates achieve. But it also imposes public-market price discipline far sooner, and it keeps ordinary Indian investors inside the compounding curve rather than outside it, waiting for a proxy fund to overprice their way in.
The lesson for executives everywhere is not that private capital is bad or that IPOs are morally superior. It is that the length of the private period is no longer a neutral financing choice. It is a decision about who gets to own the growth, and every year it stretches longer, the answer tilts further away from the public.



